Novel agents in Waldenström macroglobulinemia

Por Issa, Ghayas C, Ghobrial, Irene M, Roccaro, Aldo M
Publicado em 2011

Epigenetic modifications as key regulators of Waldenstrom's Macroglobulinemia biology

Por Sacco, Antonio, Issa, Ghayas C, Zhang, Yong, Liu, Yang, Maiso, Patricia, Ghobrial, Irene M, Roccaro, Aldo M
Publicado em 2010

Impact of complete molecular response on survival in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

Por Short, Nicholas J., Jabbour, Elias, Sasaki, Koji, Patel, Keyur, O’Brien, Susan M., Cortes, Jorge E., Garris, Rebecca, Issa, Ghayas C., Garcia-Manero, Guillermo, Luthra, Rajyalakshmi, Thomas, Deborah, Kantarjian, Hagop, Ravandi, Farhad
Publicado no Blood (2016)

Hyper-CVAD + ponatinib vs. hyper-CVAD + dasatinib as frontline therapy for Ph-positive ALL: a propensity score analysis

Por Sasaki, Koji, Jabbour, Elias, Ravandi, Farhad, Short, Nicholas J., Thomas, Deborah, Garcia-Manero, Guillermo, Daver, Naval, Kadia, Tapan, Konopleva, Marina, Jain, Nitin, Issa, Ghayas C., Jeanis, Vicki, Moore, Gal, Garris, Rebecca, Pemmaraju, Naveen, Cortes, Jorge E., O'Brien, Susan, Kantarjian, Hagop
Publicado no Cancer (2016)

Clonal chromosomal abnormalities appearing in Philadelphia chromosome–negative metaphases during CML treatment

Por Issa, Ghayas C., Kantarjian, Hagop M., Gonzalez, Graciela Nogueras, Borthakur, Gautam, Tang, Guilin, Wierda, William, Sasaki, Koji, Short, Nicholas J., Ravandi, Farhad, Kadia, Tapan, Patel, Keyur, Luthra, Raja, Ferrajoli, Alessandra, Garcia-Manero, Guillermo, Rios, Mary Beth, Dellasala, Sara, Jabbour, Elias, Cortes, Jorge E.
Publicado no Blood (2017)

Prognostic significance of day 14 bone marrow evaluation in adults with Philadelphia chromosome-negative ALL

Por Short, Nicholas J., Kantarjian, Hagop, Sasaki, Koji, Cortes, Jorge E., Ravandi, Farhad, Thomas, Deborah, Garcia-Manero, Guillermo, Khouri, Issa, Kebriaei, Partow, Champlin, Richard E., Pierce, Sherry, Issa, Ghayas C., Konopleva, Marina, Kadia, Tapan M., Bueso-Ramos, Carlos, Khoury, Joseph D., Jain, Nitin, O’Brien, Susan M., Jabbour, Elias
Publicado no Cancer (2016)

Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative ALL in the era of MRD

Por Issa, Ghayas C., Kantarjian, Hagop, Yin, C. Cameron, Qiao, Wei, Ravandi, Farhad, Thomas, Deborah, Short, Nicholas J., Sasaki, Koji, Garcia-Manero, Guillermo, Kadia, Tapan M., Cortes, Jorge E., Daver, Naval, Borthakur, Gautam, Jain, Nitin, Konopleva, Marina, Khouri, Issa, Kebriaei, Partow, Champlin, Richard E., Pierce, Sherry, O'Brien, Susan M., Jabbour, Elias
Publicado no Cancer (2016)

Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase...

Por Short, Nicholas J., Kantarjian, Hagop M., Sasaki, Koji, Ravandi, Farhad, Ko, Heidi, Yin, C. Cameron, Garcia-Manero, Guillermo, Cortes, Jorge E., Garris, Rebecca, O'Brien, Susan M., Patel, Keyur, Khouri, Maria, Thomas, Deborah, Jain, Nitin, Kadia, Tapan M., Daver, Naval, Benton, Christopher B., Issa, Ghayas C., Konopleva, Marina, Jabbour, Elias
Publicado no Am J Hematol (2017)

Prognostic factors and survival outcomes in patients with blast phase CML (CML-BP) in the tyrosine kinase inhibitor (TKI) era: cohort study of 477 patients

Por Jain, Preetesh, Kantarjian, Hagop, Ghorab, Ahmed, Sasaki, Koji, Jabbour, Elias, Gonzalez, Graciela Nogueras, Kanagal-Shamanna, Rashmi, Issa, Ghayas C., Garcia-Manero, Guillermo, Devendra, KC, Dellasala, Sara, Pierce, Sherry, Konopleva, Marina, Wierda, William G., Verstovsek, Srdan, Daver, Naval, Kadia, Tapan M., Borthakur, Gautam, O’Brien, Susan, Estrov, Zeev, Ravandi, Farhad, Cortes, Jorge
Publicado no Cancer (2017)

TP53 Mutation Does Not Confer a Poor Outcome in Adult ALL Treated with Frontline Hyper-CVAD-based Regimens

Por Kanagal-Shamanna, Rashmi, Jain, Preetesh, Takahashi, Koichi, Short, Nicholas J., Tang, Guilin, Issa, Ghayas C., Ravandi, Farhad, Garcia-Manero, Guillermo, Yin, Cameron C., Luthra, Rajyalakshmi, Patel, Keyur P., Khoury, Joseph D., Montalban-Bravo, Guillermo, Sasaki, Koji, Kadia, Tapan M., Borthakur, Gautam, Konopleva, Marina, Jain, Nitin, Garris, Rebecca, Pierce, Sherry, Wierda, William, Estrov, Zeev, Cortes, Jorge, O’Brien, Susan, Kantarjian, Hagop, Jabbour, Elias
Publicado no Cancer (2017)

BET bromodomain inhibition as a therapeutic strategy to target c-Myc

Por Delmore, Jake E., Issa, Ghayas C., Lemieux, Madeleine E., Rahl, Peter B., Shi, Junwei, Jacobs, Hannah M., Kastritis, Efstathios, Gilpatrick, Timothy, Paranal, Ronald M., Qi, Jun, Chesi, Marta, Schinzel, Anna, McKeown, Michael R., Heffernan, Timothy P., Vakoc, Christopher R., Bergsagel, P. Leif, Ghobrial, Irene M., Richardson, Paul G., Young, Richard A., Hahn, William C., Anderson, Kenneth C., Kung, Andrew L., Bradner, James E., Mitsiades, Constantine S.
Publicado em 2011

Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia

Por Morita, Kiyomi, Kantarjian, Hagop M., Wang, Feng, Yan, Yuanqing, Bueso-Ramos, Carlos, Sasaki, Koji, Issa, Ghayas C., Wang, Sa, Jorgensen, Jeffrey, Song, Xingzhi, Zhang, Jianhua, Tippen, Samantha, Thornton, Rebecca, Coyle, Marcus, Little, Latasha, Gumbs, Curtis, Pemmaraju, Naveen, Daver, Naval, DiNardo, Courtney D., Konopleva, Marina, Andreeff, Michael, Ravandi, Farhad, Cortes, Jorge E., Kadia, Tapan, Jabbour, Elias, Garcia-Manero, Guillermo, Patel, Keyur P., Futreal, P. Andrew, Takahashi, Koichi
Publicado no J Clin Oncol (2018)